TY - JOUR
T1 - Assessment of sexual health in aging men in Europe: Development and validation of the European male ageing study sexual function questionnaire
AU - O'Connor, Daryl B.
AU - Corona, Giovanni
AU - Tajar, Abdelouahid
AU - Pye, Stephen
AU - Finn, Joseph D.
AU - Bartfai, Gyorgy
AU - Boonen, Steven
AU - Casanueva, Felipe F.
AU - Giwercman, Aleksander
AU - Huhtaniemi, Ilpo T.
AU - Kula, Krzysztof
AU - O'Neill, Terence W.
AU - Pendleton, Neil
AU - Punab, Margus
AU - Silman, Alan J.
AU - Vanderschueren, Dirk
AU - Wu, Frederick C W
AU - Forti, Gianni
AU - Petrone, Luisa
AU - Cilotti, Antonio
AU - Lean, Mike
AU - Han, Thang
AU - Borghs, Herman
AU - Slowikowska-Hilczer, Jolanta
AU - Walczak-Jedrzejowska, Renata
AU - Steer, Philip
AU - Ocampo, Marta
AU - Lage, Mary
AU - Bartfai, George
AU - Földesi, Imre
AU - Fejes, Imre
AU - Korrovitz, Paul
AU - Jiang, Min
AU - Lee, David
N1 - Journal Article Research Support, Non-U.S. Gov't United States
PY - 2008/6
Y1 - 2008/6
N2 - Introduction. Assessment of male sexual dysfunction has been the focus of substantial scientific effort. Less research has focused on the development of instruments for the measurement of sexual functioning in aging men. Aims. The aims of this study were: (i) to characterize the psychometric properties of a new brief, reliable, and valid measure of male sexual functioning for use in a large population survey of middle-aged and elderly European men; and (ii) specifically, to determine whether the new instrument, the European Male Ageing Study-sexual function questionnaire (EMAS-SFQ), discriminates between men with high and low levels of circulating testosterone (T) (total T, free T, and bioavailable T). Method. One thousand six hundred men aged 40-79 years completed the self-administered EMAS-SFQ, the Beck depression inventory, and provided a blood sample for assessment of sex hormones. Eighty-five men aged 35-74 years completed the EMAS-SFQ twice, 2 weeks apart to examine the test-retest reliability of the instrument. Main Outcome Measures. Scores on the EMAS-SFQ in relation to age and T levels. Results. Principal component analysis showed that the EMAS-SFQ had four distinct domains (overall sexual functioning [OSF], masturbation, sexual functioning-related distress, and change in sexual functioning). The instrument demonstrated excellent internal and test-retest reliability, as well as convergent, divergent, and discriminant validity. Men with the lowest levels of total, free, and bioavailable T reported lower OSF scores compared to men with the highest T levels. Conclusions. The EMAS-SFQ is a valid and reproducible instrument, sensitive to age and T levels. It should be suitable for the assessment of sexual health in population samples of men in epidemiological studies of aging. © 2008 International Society for Sexual Medicine.
AB - Introduction. Assessment of male sexual dysfunction has been the focus of substantial scientific effort. Less research has focused on the development of instruments for the measurement of sexual functioning in aging men. Aims. The aims of this study were: (i) to characterize the psychometric properties of a new brief, reliable, and valid measure of male sexual functioning for use in a large population survey of middle-aged and elderly European men; and (ii) specifically, to determine whether the new instrument, the European Male Ageing Study-sexual function questionnaire (EMAS-SFQ), discriminates between men with high and low levels of circulating testosterone (T) (total T, free T, and bioavailable T). Method. One thousand six hundred men aged 40-79 years completed the self-administered EMAS-SFQ, the Beck depression inventory, and provided a blood sample for assessment of sex hormones. Eighty-five men aged 35-74 years completed the EMAS-SFQ twice, 2 weeks apart to examine the test-retest reliability of the instrument. Main Outcome Measures. Scores on the EMAS-SFQ in relation to age and T levels. Results. Principal component analysis showed that the EMAS-SFQ had four distinct domains (overall sexual functioning [OSF], masturbation, sexual functioning-related distress, and change in sexual functioning). The instrument demonstrated excellent internal and test-retest reliability, as well as convergent, divergent, and discriminant validity. Men with the lowest levels of total, free, and bioavailable T reported lower OSF scores compared to men with the highest T levels. Conclusions. The EMAS-SFQ is a valid and reproducible instrument, sensitive to age and T levels. It should be suitable for the assessment of sexual health in population samples of men in epidemiological studies of aging. © 2008 International Society for Sexual Medicine.
KW - Aging
KW - Male sexual function
KW - Middle-aged and elderly men
KW - Testosterone
U2 - 10.1111/j.1743-6109.2008.00781.x
DO - 10.1111/j.1743-6109.2008.00781.x
M3 - Article
SN - 1743-6095
VL - 5
SP - 1374
EP - 1385
JO - Journal of Sexual Medicine
JF - Journal of Sexual Medicine
IS - 6
ER -
